Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SOPHiA GENETICS has developed a cloud-based AI-driven SaaS platform—SOPHiA DDM™—that analyzes complex multimodal health data to generate actionable insights for clinicians and researchers. Their technology supports over two million genomic profiles analyzed across more than 770 institutions worldwide. Products are available for research use globally, with some CE-IVD marked solutions for clinical diagnostics in Europe. The company’s impact includes improved precision oncology workflows and rare disease diagnosis support. No direct clinical trial results are reported as the company does not develop therapeutics but enables better patient outcomes through advanced analytics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SOPHiA GENETICS.